Cargando…

Frailty in Nonalcoholic Fatty Liver Cirrhosis: A Comparison with Alcoholic Cirrhosis, Risk Patterns, and Impact on Prognosis

BACKGROUND: Physical frailty increases susceptibility to stressors and predicts adverse outcomes of cirrhosis. Data on disease course in different etiologies are scarce, so we aimed to compare the prevalence and risk factors of frailty and its impact on prognosis in nonalcoholic fatty liver (NAFLD)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Skladany, Lubomir, Molcan, Pavol, Vnencakova, Jana, Vrbova, Petra, Kukla, Michal, Laffers, Lukas, Koller, Tomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163557/ https://www.ncbi.nlm.nih.gov/pubmed/34095016 http://dx.doi.org/10.1155/2021/5576531

Ejemplares similares

Adherence to Oral Nutritional Supplements After Being Discharged from the Hospital is Low but Improves Outcome in Patients with Advanced Chronic Liver Disease
por: Skladany, Lubomir, et al.
Publicado: (2021)

Applicability and prognostic value of frailty assessment tools among hospitalized patients with advanced chronic liver disease
por: Skladany, Lubomir, et al.
Publicado: (2021)

Liver injury associated with the use of selective androgen receptor modulators and post-cycle therapy: Two case reports and literature review
por: Koller, Tomas, et al.
Publicado: (2021)

Irisin in Liver Cirrhosis
por: Kukla, Michał, et al.
Publicado: (2020)

Comparison of the quality of life of patients with liver cirrhosis before and during the COVID-19 lockdown in Slovakia
por: Skladaný, Ľ., et al.
Publicado: (2023)

Low back pain in patients hospitalised with liver cirrhosis- a retrospective study
por: Bednár, R., et al.
Publicado: (2023)

Challenging management of severe chronic disorders in acute pandemic situation: Chronic liver disease under COVID-19 pandemic as the proof-of-principle model to orchestrate the measures in 3PM context
por: Skladany, Lubomir, et al.
Publicado: (2021)

Alcohol Use Relapse Following Liver Transplantation for Alcoholic Liver Disease
por: Skladany, Lubomir, et al.
Publicado: (2019)

Towards an evaluation of alcoholic liver cirrhosis and nonalcoholic fatty liver disease patients with hematological scales
por: Michalak, Agata, et al.
Publicado: (2020)

Sarcopenia and Frailty in Liver Cirrhosis
por: Nishikawa, Hiroki, et al.
Publicado: (2021)

Plateletcrit and Mean Platelet Volume in the Evaluation of Alcoholic Liver Cirrhosis and Nonalcoholic Fatty Liver Disease Patients
por: Michalak, Agata, et al.
Publicado: (2021)

Alcohol and Cirrhosis
Publicado: (1898)

The impact of nonalcoholic fatty liver disease on chronic viral hepatitis – progression to cirrhosis
por: Olariu, Cristina, et al.
Publicado: (2013)

A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease
por: Caussy, Cyrielle, et al.
Publicado: (2019)

Diabetes and Risk of Hepatocellular Carcinoma in Cirrhosis Patients with Nonalcoholic Fatty Liver Disease
por: Teng, Pai-Chi, et al.
Publicado: (2023)

Differences in Fecal Short-Chain Fatty Acids between Alcoholic Fatty Liver-Induced Cirrhosis and Non-alcoholic (Metabolic-Associated) Fatty Liver-Induced Cirrhosis
por: Cao, Xinlu, et al.
Publicado: (2023)

Clinical indicators for progression of nonalcoholic steatohepatitis to cirrhosis
por: Seen, Tasur Kumar, et al.
Publicado: (2021)

Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Cirrhosis Confirmed by Liver Histology after 14 Years
por: Kawanaka, Miwa, et al.
Publicado: (2020)

Liver Cirrhosis in Alcoholics
por: Demeulenaere, L., et al.
Publicado: (1977)

Nonalcoholic fatty liver disease‐related cirrhosis is commonly unrecognized and associated with hepatocellular carcinoma
por: Bertot, Luis C., et al.
Publicado: (2017)

Diet Quality Association with Nonalcoholic Fatty Liver Disease by Cirrhosis Status: The Multiethnic Cohort
por: Park, Song-Yi, et al.
Publicado: (2020)

The empirical dietary inflammatory pattern score and the risk of nonalcoholic fatty liver disease and cirrhosis
por: Ibrahim, Maryam K., et al.
Publicado: (2023)

Cognitive Impairment and Physical Frailty in Patients With Cirrhosis
por: Berry, Kacey, et al.
Publicado: (2021)

Predictive Factors for the Prognosis of Alcoholic Liver Cirrhosis
por: Trifan, Anca, et al.
Publicado: (2022)

Acute-on-chronic liver failure: a single-centre experience
por: Skladaný, Ľubomír, et al.
Publicado: (2020)

Diastolic Dysfunction and Severity of Cirrhosis in Nonalcoholic Cirrhotic Patients
por: Salari, A., et al.
Publicado: (2013)

Hepatocellular carcinoma in nonalcoholic fatty liver disease with or without cirrhosis: a population-based study
por: Pinyopornpanish, Kanokwan, et al.
Publicado: (2021)

Incidence of hepatocellular carcinoma in nonalcoholic fatty liver disease without cirrhosis or advanced liver fibrosis
por: Behari, Jaideep, et al.
Publicado: (2023)

Relationship between alcohol consumption and adverse childhood experiences in college students–A cross-sectional study
por: Šulejová, Karolína, et al.
Publicado: (2022)

Role of Alcohol in the Pathogenesis of Cirrhosis
por: Klatskin, Gerald
Publicado: (1953)

Differences in complications between hepatitis B-related cirrhosis and alcohol-related cirrhosis
por: Zhuang, Yu-Pei, et al.
Publicado: (2021)

Comparison of Electrocardiogram and QT Interval between Viral Hepatitis Cirrhosis and Alcoholic Cirrhosis
por: Lu, Li-Hong, et al.
Publicado: (2022)

Complications Requiring Hospital Admission and Causes of In-Hospital Death over Time in Alcoholic and Nonalcoholic Cirrhosis Patients
por: Kim, Hee Yeon, et al.
Publicado: (2016)

Emerging advances in the pharmacologic treatment of nonalcoholic steatohepatitis and related cirrhosis
por: Sinakos, Emmanouil, et al.
Publicado: (2022)

Treatment of an Adolescent Female With Nonalcoholic Steatohepatitis–Related Cirrhosis With Liraglutide
por: Yuen, Christina, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease Cirrhosis: A Review of Its Epidemiology, Risk Factors, Clinical Presentation, Diagnosis, Management, and Prognosis
por: Li, Bei, et al.
Publicado: (2018)

Rare leptin in non-alcoholic fatty liver cirrhosis: A case report
por: Nong, Yao-Bin, et al.
Publicado: (2022)

Muscle at Risk: The Multiple Impacts of Ammonia on Sarcopenia and Frailty in Cirrhosis
por: Chen, Hui-Wei, et al.
Publicado: (2016)

Sex Differences in the Association Between Frailty and Sarcopenia in Patients With Cirrhosis
por: Fozouni, Laila, et al.
Publicado: (2019)

Cirrhosis and frailty assessment in elderly patients: A paradoxical result
por: Federico, Alessandro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kl5iu24j6vspveura0ave2srof